Meetings of creditors (CVL)
APEX PHARMACEUTICALS LTD.
A virtual creditors' meeting for APEX PHARMACEUTICALS LTD is scheduled for 30 September 2026 at 12:30 pm, with proxy details and contact information provided.
Notice details
- Company
- APEX PHARMACEUTICALS LTD
- Company number
- 04528131
- Registered office
- Interpath Ltd, 10 Fleet Place, London, EC4M 7RB
- Office holder(s)/Liquidator(s)
- Anthony Johnson-Magee; Michael Leeds
- Office holder number(s)
- 32350; 15330
- Date of appointment
- 08 May 2025
- Meeting date/time
- 30 September 2026 at 12:30 pm
- Meeting type
- Virtual meeting of creditors
- Proxy deadline
- 4.00 p.m. on 29 September 2026
- Contact
- Lewis Powell on 0203 989 2710
What this notice means
Liquidation winds a company up: a licensed insolvency practitioner (the liquidator) is appointed to sell the company's assets and distribute the proceeds to creditors in the order fixed by law, after which the company is dissolved. A creditors' voluntary liquidation (CVL) is started by the company's own directors and shareholders once it can no longer pay its debts as they fall due.
Read more: What is Liquidation?.
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If APEX PHARMACEUTICALS LTD. owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at APEX PHARMACEUTICALS LTD. or something similar, start the conversation early.
If your business is under pressure — creditors circling, a petition threatened, or cash running out — acting early changes the outcome. K2 has helped UK directors turn things around since 1990. Talk to us in confidence.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Has APEX PHARMACEUTICALS LTD. gone into liquidation?
The London Gazette published a Meetings of creditors (CVL) for APEX PHARMACEUTICALS LTD. (company no. 04528131) on 08 September 2026. Liquidation winds a company up: a licensed insolvency practitioner (the liquidator) is appointed to sell the company's assets and distribute the proceeds to creditors in the order fixed by law, after which the company is dissolved. A creditors' voluntary liquidation (CVL) is started by the company's own directors and shareholders once it can no longer pay its debts as they fall due.
What does a Meetings of creditors (CVL) mean?
Liquidation winds a company up: a licensed insolvency practitioner (the liquidator) is appointed to sell the company's assets and distribute the proceeds to creditors in the order fixed by law, after which the company is dissolved. A creditors' voluntary liquidation (CVL) is started by the company's own directors and shareholders once it can no longer pay its debts as they fall due.
APEX PHARMACEUTICALS LTD. owes me money — what can I do?
If APEX PHARMACEUTICALS LTD. owes you money you are a creditor in the process. The insolvency practitioner named in the notice will write to known creditors and invite claims. Unsecured creditors rank after fixed-charge holders, the costs of the insolvency, preferential creditors and floating-charge holders, so recovery depends on what is left in the estate.
I worked for APEX PHARMACEUTICALS LTD. — how do I claim what I am owed?
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from the company or from K2. The insolvency practitioner named in this notice should give you a case reference to claim with.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.